Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for VREX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 36.44%
March 31, 2026 33.61%
December 31, 2025 33.30%
September 30, 2025 33.99%
June 30, 2025 33.25%
March 31, 2025 36.03%
December 31, 2024 34.28%
September 30, 2024 32.62%
June 30, 2024 31.99%
March 31, 2024 31.91%
December 31, 2023 30.05%
September 30, 2023 33.60%
June 30, 2023 32.86%
March 31, 2023 31.86%
December 31, 2022 30.79%
September 30, 2022 31.46%
June 30, 2022 35.57%
March 31, 2022 34.56%
December 31, 2021 33.20%
September 30, 2021 33.85%
June 30, 2021 36.88%
March 31, 2021 31.79%
Date Value
December 31, 2020 32.35%
September 30, 2020 29.00%
June 30, 2020 21.55%
March 31, 2020 29.70%
December 31, 2019 30.68%
September 30, 2019 34.09%
June 30, 2019 33.20%
March 31, 2019 34.52%
December 31, 2018 32.31%
September 30, 2018 30.47%
June 30, 2018 34.31%
March 31, 2018 36.08%
December 31, 2017 36.83%
September 30, 2017 36.07%
June 30, 2017 37.21%
March 31, 2017 37.92%
December 31, 2016 39.07%
September 30, 2016 42.13%
June 30, 2016 41.61%
March 31, 2016 39.45%
December 31, 2015 38.90%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sensus Healthcare, Inc. 33.58%
Butterfly Network, Inc. 71.41%
GE Healthcare Technologies, Inc. 40.72%
EBR Systems, Inc. 13.01%
Accuray, Inc. 34.76%